End-of-Life Care of Patients with Idiopathic Pulmonary Fibrosis

Micco, Assunta; Sorbo, Antonio Di; Donno, Mario Del

doi:10.1007/978-3-030-26664-6_33

Cited by 1 publication

(2 citation statements)

References 53 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…However, religious and cultural values, often superimposed on social or psychological needs, must be recognized and considered [16]. Notably, the study of Evangelista et al that examined thirtynine publications on the relevance of the spiritual dimension in the care of patients with palliative care, pointed out that religious and spiritual beliefs and performing spiritual practices, like meditation and praying, for example, can reduce anxiety and distress caused by terminal diseases, because these facilitate easing patients' mind [17].…”

Section: The Decision-making Process In the Planning Of The Pc And Th...mentioning

confidence: 99%

“…Care for people at the EoL, rather than being guided by rigorous protocols, should be based on clinical evidence and tailored to the patient's preferences and needs, in order to create individual-ized care plans in an early timing [16]. The guidelines of the General Medical Council on the EoL provide recommendations on communication and shared decision-making and constitute a useful resource for all health professionals [26].…”

Section: The Timing Of Palliative Care and Eol Treatmentsmentioning

confidence: 99%

See 1 more Smart Citation

Palliative care and end of life management in patients with idiopathic pulmonary fibrosis

et al. 2023

View full text Add to dashboard Cite

Idiopathic pulmonary fibrosis (IPF) is a chronic disease with an unknown etiology that causes deterioration of the structure of the lung parenchyma, resulting in a severe and progressive decline in respiratory function and early mortality. IPF is essentially an incurable disease, with a mean overall survival of 5 years in approximately 20% of patients without treatment. The combination of a poor prognosis, uncertainty about the disease's progression, and the severity of symptoms has a significant impact on the quality of life of patients and their families. New antifibrotic drugs have been shown to slow disease progression, but their impact on health-related quality of life (HRQoL) has to be proven yet. To date, studies have shown that palliative care can improve symptom management, HRQoL, and end-of-life care (EoL) in patients with IPF, reducing critical events, hospitalization, and health costs. As a result, it is essential for proper health planning and patient management to establish palliative care early and in conjunction with other therapies, beginning with the initial diagnosis of the disease.

show abstract

Section: The Decision-making Process In the Planning Of The Pc And Th...mentioning

confidence: 99%

Section: The Timing Of Palliative Care and Eol Treatmentsmentioning

confidence: 99%